1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Rising Cancer Prevalence Coupled with Technological Advancements Fueling the Market Growth
4.2.1.2. Supporting Initiatives for Early Cancer Diagnosis and Creating Awareness Driving the Market Growth
4.2.1.3. Growing Adoption and Supporting Initiatives for Precision Cancer Diagnostics Creating Opportunities for the Market Players
4.2.1.4. Insufficiencies in the Implementation of Cancer Screening Programs: A Challenge for Cancer Diagnosis in Europe
4.2.2. Factor Analysis
4.3. Trends
4.4. Regulatory Analysis
4.4.1. Regulatory Analysis for IVD Technologies
4.4.2. Regulatory Analysis for Diagnostic Imaging Devices
4.5. Porter’s Five Forces Analysis: Diagnostic Imaging Technologies for Cancer Screening
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
4.6. Porter’s Five Forces Analysis: IVD Technologies for Cancer Screening
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
4.7. Pricing Analysis
5. Europe Cancer Diagnostics Market–by Product
5.1. Overview
5.2. In Vitro Diagnostics
5.2.1. IVD Consumables
5.2.1.1. Kits & Assays
5.2.1.2. Reagents
5.2.2. IVD Instruments
5.2.2.1. Sequencers
5.2.2.2. Polymerase Chain Reaction (PCR) Systems
5.2.2.3. Immunoassay Analyzers
5.2.2.4. Microarray Readers
5.2.2.5. Other IVD Instruments
5.2.3. IVD Software & Services
5.3. Diagnostic Imaging
5.3.1. Imaging Instruments
5.3.1.1. Computed Tomography (CT)
5.3.1.2. Mammography
5.3.1.3. Magnetic Resonance Imaging (MRI)
5.3.1.4. Ultrasound
5.3.1.5. Other Imaging Instruments
5.3.2. Imaging Consumables
5.3.2.1. Contrast Agents
5.3.2.2. Syringes & Injectors
5.3.2.3. Contrast Delivery Systems
5.3.2.4. Skin Markers
5.3.2.5. Phantoms
5.3.2.6. Other Imaging Consumables
5.3.3. Imaging Software & Services
6. Europe Cancer Diagnostics Market–by Cancer Type
6.1. Overview
6.2. Breast Cancer
6.3. Lung Cancer
6.4. Colorectal Cancer
6.5. Prostate Cancer
6.6. Other Cancer Types
7. Europe Cancer Diagnostics Market–by End User
7.1. Overview
7.2. Hospitals & Diagnostic Laboratories
7.3. Diagnostic Imaging Centers
7.4. Pharmaceutical & Biotechnology Companies
7.5. Academic & Research Institutes
8. Europe Cancer Diagnostics Market Assessment— by Geography
8.1. Overview
8.2. Germany
8.3. France
8.4. U.K.
8.5. Italy
8.6. Spain
8.7. Switzerland
8.8. Netherlands
8.9. Rest of Europe (RoE)
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Market Share Analysis (2023)
9.4.1. Europe Cancer IVD Market Share Analysis (2023)
9.4.1.1. F. Hoffmann-La Roche Ltd (Switzerland)
9.4.1.2. Thermo Fisher Scientific Inc. (U.S.)
9.4.1.3. Illumina, Inc. (U.S.)
9.4.2. Europe Diagnostic Imaging Market Share Analysis (2023)
9.4.2.1. GE Healthcare Technologies Inc. (U.S.)
9.4.2.2. Siemens Healthineers AG (Germany)
9.4.2.3. Hologic, Inc. (U.S.)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments, SWOT Analysis)
10.1. F. Hoffmann-La Roche Ltd
10.2. Thermo Fisher Scientific Inc.
10.3. QIAGEN N.V.
10.4. Abbott Laboratories
10.5. Illumina, Inc.
10.6. Siemens Healthineers AG
10.7. GE Healthcare Technologies Inc.
10.8. Hologic, Inc.
10.9. Koninklijke Philips N.V.
10.10. Fujifilm Holdings Corporation
10.11. Canon Medical Systems Corporation
(Note: SWOT Analysis of the Top 6 Companies Will Be Provided)
11. Appendix
11.1. Related Reports
List of Tables
Table 1 Europe: Single and Multi Biomarker Test Availability by Country, 2021
Table 2 Average Selling Prices: IVD Instruments
Table 3 Average Selling Prices: Diagnostic Imaging Instruments
Table 4 Europe Cancer Diagnostics Market, by Product, 2022–2031 (USD Million)
Table 5 Europe Cancer In Vitro Diagnostics Market, by Product, 2022–2031 (USD Million)
Table 6 Europe Cancer In Vitro Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Europe Cancer IVD Consumables Market, by Type, 2022–2031 (USD Million)
Table 8 Europe Cancer IVD Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 9 IVD Kits & Assays Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 10 IVD Reagents Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 11 Europe Cancer IVD Instruments Market, by Type, 2022–2031 (USD Million)
Table 12 Europe Cancer IVD Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Sequencers Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 14 Polymerase Chain Reaction (PCR) Systems Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 15 Immunoassay Analyzers Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 16 Microarray Readers Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 17 Other IVD Instruments Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 18 Europe Cancer IVD Software & Services Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Europe Imaging-Based Cancer Diagnostics Market, by Product, 2022–2031 (USD Million)
Table 20 Europe Imaging-Based Cancer Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Europe Cancer Diagnostic Imaging Instruments Market, by Type, 2022–2031 (USD Million)
Table 22 Europe Cancer Diagnostic Imaging Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Computed Tomography (CT) Scanners per 1,000,000 Inhabitants in European Countries (2021)
Table 24 CT Scanners Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 25 Mammography Machines per 1,000,000 Inhabitants in European Countries (2021)
Table 26 Mammography Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 27 Magnetic Resonance Imaging (MRI) Units per 1,000,000 Inhabitants in European Countries (2021)
Table 28 MRI Scanners Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 29 Ultrasound Scanners Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 30 Other Imaging Instruments Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 31 Europe Cancer Diagnostic Imaging Consumables Market, by Type, 2022–2031 (USD Million)
Table 32 Europe Cancer Diagnostic Imaging Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 33 Contrast Agents Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 34 Syringes & Injectors Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 35 Contrast Delivery Systems Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 36 Skin Markers Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 37 Phantoms Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 38 Other Imaging Consumables Market for Cancer Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 39 Europe Cancer Diagnostic Imaging Software & Services Market, by Country/Region, 2022–2031 (USD Million)
Table 40 Europe Cancer Diagnostics Market, by Cancer Type, 2022–2031 (USD Million)
Table 41 Number of New Breast Cancer Cases in European Countries, 2022–2030
Table 42 Europe Cancer Diagnostics Market for Breast Cancer, by Country/Region, 2022–2031 (USD Million)
Table 43 Europe Cancer Diagnostics Market for Lung Cancer, by Country/Region, 2022–2031 (USD Million)
Table 44 Europe Cancer Diagnostics Market for Colorectal Cancer, by Country/Region, 2022–2031 (USD Million)
Table 45 Number Of New Prostate Cancer Cases In European Countries, 2022–2030
Table 46 Europe Cancer Diagnostics Market for Prostate Cancer, by Country/Region, 2022–2031 (USD Million)
Table 47 Number of Other Cancer Cases in European Countries, 2022–2030
Table 48 Europe Cancer Diagnostics Market for Other Cancer Types, by Country/Region, 2022–2031 (USD Million)
Table 49 Europe Cancer Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 50 Number of Hospitals in European Countries, 2021
Table 51 Europe Cancer Diagnostics Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 52 Europe Cancer Diagnostics Market for Diagnostic Imaging Centers, by Country/Region, 2022–2031 (USD Million)
Table 53 Europe Cancer Diagnostics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 54 Europe Cancer Diagnostics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 55 Europe: Cancer Diagnostics Market, by Country/Region, 2022—2031 (USD Million)
Table 56 Germany: Key Macro & Micro Indicators
Table 57 Germany: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 58 Germany: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 59 Germany: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 60 Germany: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 61 Germany: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 62 Germany: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 63 Germany: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 64 Germany: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 65 Germany: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 66 France: Healthcare Expenditure, 2017–2020 (USD Million)
Table 67 France: Key Macro & Micro Indicators
Table 68 France: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 69 France: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 70 France: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 71 France: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 72 France: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 73 France: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 74 France: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 75 France: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 76 France: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 77 U.K.: Key Macro & Micro Indicators
Table 78 U.K.: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 79 U.K.: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 80 U.K: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 81 U.K: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 82 U.K.: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 83 U.K.: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 84 U.K.: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 85 U.K.: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 86 U.K.: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 87 Italy: Key Macro & Micro Indicators
Table 88 Italy: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 89 Italy: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 90 Italy: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 91 Italy: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 92 Italy: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031(USD Million)
Table 93 Italy: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 94 Italy: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 95 Italy: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 96 Italy: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 97 Spain: Key Macro & Micro Indicators
Table 98 Spain: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 99 Spain: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 100 Spain: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 101 Spain: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 102 Spain: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 103 Spain: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 104 Spain: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 105 Spain: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 106 Spain: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 107 Switzerland: Key Macro & Micro Indicators
Table 108 Switzerland: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 109 Switzerland: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 110 Switzerland: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 111 Switzerland: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 112 Switzerland: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 113 Switzerland: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 114 Switzerland: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 115 Switzerland: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 116 Switzerland: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 117 Netherlands: Key Macro & Micro Indicators
Table 118 Netherlands: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 119 Netherlands: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 120 Netherlands: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 121 Netherlands: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 122 Netherlands: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 123 Netherlands: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 124 Netherlands: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 125 Netherlands: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 126 Netherlands: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 127 Rest Of Europe: Number Of New Cancer Cases, by Country, 2022 Vs. 2030
Table 128 Rest Of Europe: Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 129 Rest Of Europe: Cancer IVD Market, by Product, 2022—2031 (USD Million)
Table 130 Rest Of Europe: Cancer IVD Instruments Market, by Type, 2022—2031 (USD Million)
Table 131 Rest Of Europe: Cancer IVD Consumables Market, by Type, 2022—2031 (USD Million)
Table 132 Rest Of Europe: Imaging-Based Cancer Diagnostics Market, by Product, 2022—2031 (USD Million)
Table 133 Rest Of Europe: Cancer Diagnostic Imaging Instruments Market, by Type, 2022—2031 (USD Million)
Table 134 Rest Of Europe: Cancer Diagnostic Imaging Consumables Market, by Type, 2022—2031 (USD Million)
Table 135 Rest Of Europe: Cancer Diagnostics Market, by Cancer Type, 2022—2031 (USD Million)
Table 136 Rest Of Europe: Cancer Diagnostics Market, by End User, 2022—2031 (USD Million)
Table 137 Recent Developments, by Company, 2020-2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown Of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth for ecast Approach
Figure 7 Europe Cancer Diagnostics Market, by Product, 2024 VS. 2031 (USD Million)
Figure 8 Europe Cancer Diagnostics Market, by Cancer Type, 2024 VS. 2031 (USD Million)
Figure 9 Europe Cancer Diagnostics Market, by End User, 2024 VS. 2031 (USD Million)
Figure 10 Europe Cancer Diagnostics Market, by Country/Region
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Europe: Estimated Number of New Cancer Cases 2020 VS. 2035
Figure 13 Eu Regulatory Pathway - IVDR 2017/746
Figure 14 Porter’s Five forces Analysis
Figure 15 Porter’s Five forces Analysis
Figure 16 Europe Cancer Diagnostics Market, by Product, 2024 VS. 2031 (USD Million)
Figure 17 Europe Cancer Diagnostics Market, by Cancer Type, 2024 VS. 2031 (USD Million)
Figure 18 Number of New Lung Cancer Cases in European Countries, 2022–2030
Figure 19 Number of New Colon Cancer Cases in European Countries, 2022–2030
Figure 20 Number of New Rectal Cancer Cases in European Countries, 2022–2030
Figure 21 Europe Cancer Diagnostics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 22 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 23 Number of Cancer Cases in European Countries, 2022
Figure 24 Europe Cancer Diagnostics Market, by Country, 2024 Vs. 2031 (USD Million)
Figure 25 Europe Cancer Diagnostics Market: Regional Snapshot
Figure 26 Germany: Number of New Cancer Cases, 2022—2040
Figure 27 France: Number of New Cancer Cases, 2022—2040
Figure 28 U.K.: Number of New Cancer Cases, 2022—2040
Figure 29 Italy: Number of New Cancer Cases, 2022—2040
Figure 30 Italy: Number of Biotechnolgy Firms, 2010—2021
Figure 31 Spain: Healthcare Expenditure, 2017–2021 (USD Million)
Figure 32 Spain: Number of New Cancer Cases, 2022—2040
Figure 33 Switzerland: Number of New Cancer Cases, 2022—2040
Figure 34 Switzerland: Healthcare Expenditure, 2020–2024 (USD)
Figure 35 Netherlands: Number of New Cancer Cases, 2022—2040
Figure 36 Healthcare Expenditures In Belgium, Greece, Austria, and Poland, 2018-2021 (USD Million)
Figure 37 Key Growth Strategies Adopted by Leading Players, 2020– 2024
Figure 38 Europe Cancer In Vitro Diagnostics (IVD) Market: Competitive Benchmarking
Figure 39 Europe Cancer Diagnostic Imaging Market: Competitive Benchmarking
Figure 40 Europe Cancer In Vitro Diagnostics Market Share Analysis, by Key Players, 2023 (%)
Figure 41 Europe Cancer Diagnostics Market Share Analysis for Imaging, by Key Players, 2023 (%)
Figure 42 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2022)
Figure 43 Thermo Fisher Scientific Inc.: Financial Snapshot (2022)
Figure 44 QIAGEN N.V.: Financial Snapshot (2022)
Figure 45 Abbott Laboratories: Financial Snapshot (2022)
Figure 46 Illumina, Inc.: Financial Snapshot (2022)
Figure 47 Siemens Healthineers AG: Financial Snapshot (2023)
Figure 48 GE Healthcare Technologies Inc.: Financial Snapshot (2022)
Figure 49 Hologic, Inc.: Financial Snapshot (2023)
Figure 50 Koninklijke Philips N.V.: Financial Snapshot (2022)
Figure 51 Fujifilm Holdings Corporation: Financial Snapshot (2022)
Figure 52 Canon Medical Systems Corporation (A Subsidiary Of Canon Inc.): Financial Snapshot (2022)